These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 30033062)

  • 1. The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders.
    Carmona S; Zahs K; Wu E; Dakin K; Bras J; Guerreiro R
    Lancet Neurol; 2018 Aug; 17(8):721-730. PubMed ID: 30033062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
    Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT
    J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
    Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
    Front Immunol; 2020; 11():559342. PubMed ID: 33101276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.
    Giraldo M; Lopera F; Siniard AL; Corneveaux JJ; Schrauwen I; Carvajal J; Muñoz C; Ramirez-Restrepo M; Gaiteri C; Myers AJ; Caselli RJ; Kosik KS; Reiman EM; Huentelman MJ
    Neurobiol Aging; 2013 Aug; 34(8):2077.e11-8. PubMed ID: 23582655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
    Kleinberger G; Yamanishi Y; Suárez-Calvet M; Czirr E; Lohmann E; Cuyvers E; Struyfs H; Pettkus N; Wenninger-Weinzierl A; Mazaheri F; Tahirovic S; Lleó A; Alcolea D; Fortea J; Willem M; Lammich S; Molinuevo JL; Sánchez-Valle R; Antonell A; Ramirez A; Heneka MT; Sleegers K; van der Zee J; Martin JJ; Engelborghs S; Demirtas-Tatlidede A; Zetterberg H; Van Broeckhoven C; Gurvit H; Wyss-Coray T; Hardy J; Colonna M; Haass C
    Sci Transl Med; 2014 Jul; 6(243):243ra86. PubMed ID: 24990881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM2 variants in neurodegenerative disorders in the Polish population. Homozygosity and compound heterozygosity in FTD patients.
    Peplonska B; Berdynski M; Mandecka M; Barczak A; Kuzma-Kozakiewicz M; Barcikowska M; Zekanowski C
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):407-412. PubMed ID: 29557178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.
    Rayaprolu S; Mullen B; Baker M; Lynch T; Finger E; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Josephs KA; Knopman DS; White CL; Caselli R; Mackenzie IR; Miller BL; Boczarska-Jedynak M; Opala G; Krygowska-Wajs A; Barcikowska M; Younkin SG; Petersen RC; Ertekin-Taner N; Uitti RJ; Meschia JF; Boylan KB; Boeve BF; Graff-Radford NR; Wszolek ZK; Dickson DW; Rademakers R; Ross OA
    Mol Neurodegener; 2013 Jun; 8():19. PubMed ID: 23800361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
    Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
    JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2, Microglia, and Neurodegenerative Diseases.
    Yeh FL; Hansen DV; Sheng M
    Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
    Lue LF; Schmitz C; Walker DG
    Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
    Lu Y; Liu W; Wang X
    Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
    Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
    Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2 Function in Alzheimer's Disease and Neurodegeneration.
    Ulrich JD; Holtzman DM
    ACS Chem Neurosci; 2016 Apr; 7(4):420-7. PubMed ID: 26854967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TREM2 variants that cause early dementia and increase Alzheimer's disease risk affect gene splicing.
    Kiianitsa K; Lukes ME; Hayes BJ; Brutman JN; Valdmanis PN; Bird TD; Raskind WH; Korvatska O
    Brain; 2024 Jul; 147(7):2368-2383. PubMed ID: 38226698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM2 and the Progression of Alzheimer's Disease.
    Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y
    Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury.
    Mazaheri F; Snaidero N; Kleinberger G; Madore C; Daria A; Werner G; Krasemann S; Capell A; Trümbach D; Wurst W; Brunner B; Bultmann S; Tahirovic S; Kerschensteiner M; Misgeld T; Butovsky O; Haass C
    EMBO Rep; 2017 Jul; 18(7):1186-1198. PubMed ID: 28483841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis.
    Neumann H; Takahashi K
    J Neuroimmunol; 2007 Mar; 184(1-2):92-9. PubMed ID: 17239445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.
    Dardiotis E; Siokas V; Pantazi E; Dardioti M; Rikos D; Xiromerisiou G; Markou A; Papadimitriou D; Speletas M; Hadjigeorgiou GM
    Neurobiol Aging; 2017 May; 53():194.e13-194.e22. PubMed ID: 28214109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
    Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
    J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges.
    Zgorzynska E
    Mol Cell Neurosci; 2024 Mar; 128():103917. PubMed ID: 38244651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.